By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SIGA Technologies, Inc. 

420 Lexington Avenue
Suite 620
New York  New York  10170  U.S.A.
Phone: 212-672-9100 Fax: 212-697-3130


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





Company News
SIGA (SIGA) Announces Data Safety Monitoring Board (DSMB) Approval To Complete Subject Enrollment In The Final Cohort Of Phase III Study Of TPOXX (Tecovirimat) 8/9/2016 10:23:08 AM
PharmAthene, Inc. (PIP) Receives $20 Million Payment From SIGA (SIGA) To Extend Payment Deadline 7/11/2016 6:27:26 AM
SIGA (SIGA) Announces Enrollment Of First Patients In The Final Cohort Of Phase III Study Of Tecovirimat 4/26/2016 12:36:12 PM
SIGA (SIGA) Successfully Emerges from Chapter 11 4/13/2016 6:01:00 AM
SIGA (SIGA) Commences Clinical Study For Intravenous (IV) Formulation Of TPOXX 3/17/2016 8:21:55 AM
FDA Concurs On Clinical Dose For SIGA (SIGA)’s Tecovirimat Antiviral 2/24/2016 11:25:19 AM
SIGA (SIGA) Announces That Delaware Supreme Court Affirms Court Of Chancery Opinion 12/28/2015 12:22:57 PM
SIGA (SIGA) Files Reorganization Plan to Exit from Bankruptcy 12/16/2015 6:21:03 AM
SIGA Technologies, Inc. (SIGA) Receives NASDAQ Delisting Notification 3/19/2015 12:45:36 PM
SIGA Technologies, Inc. (SIGA) Appeals Judgment Of Delaware Court Of Chancery 1/19/2015 11:25:05 AM
12345678910...
//-->